Home > Journals > The Journal of Cardiovascular Surgery > Past Issues > The Journal of Cardiovascular Surgery 2000 December;41(6) > The Journal of Cardiovascular Surgery 2000 December;41(6):871-83

CURRENT ISSUE
 

JOURNAL TOOLS

eTOC
To subscribe
Submit an article
Recommend to your librarian
 

ARTICLE TOOLS

Reprints
Permissions

 

ORIGINAL ARTICLES  VASCULAR AND ENDOVASCULAR PAPERS 

The Journal of Cardiovascular Surgery 2000 December;41(6):871-83

Copyright © 2009 EDIZIONI MINERVA MEDICA

language: English

Percutaneous endovascular treatment of peripheral aneurysms

Henry M., Amor M., Henry I., Klonaris C., Tzvetanov K., Buniet J. M., Amicabile C., Drawin T.

From Polyclinique, Essey-les-Nancy Nancy, France


PDF


Back­ground. To eval­uate the fea­sibility and effi­cacy of per­cut­aneous endo­vas­cular treat­ment of periph­eral aneu­rysms.
­Methods. ­Forty-­eight ­patients, M: 41, F: 7, ­mean age: 65.7±10.1 ­years (47-85 ­years), ­with 50 aneu­rysms ­were ­treated: 45 ­with cov­ered ­stents (­Cragg/Pas­sager 22, Cor­vita 21, Wall­graft 1, ­Endotex 1) 4 ­with non-cov­ered ­stents and 1 ­with ­stent ­graft. ­Twenty-six aneu­rysms ­located at the ­iliac ­artery, 12 at the ­femoral and 12 at the pop­li­teal ­artery. ­Mean ­lesion ­length: 61.1±21.3 mm. Per­cut­aneous ­approach ­used in all ­cases, ­femoral ante­grade (n=24), ret­ro­grade (n=23), con­tra­lat­eral (n=2), pop­li­teal (n=1). ­Stents ­used ­were 6-12 mm in diam­eter and 30-120 mm in ­length. Mul­tiple ­stents ­used to ­cover all ­lesions in 20 ­cases.
­Results. Imme­diate tech­nical suc­cess was 96% (48/50). In 1 ­case of ­long, tor­tuous femor­o­pop­li­teal aneu­rysm, it was impos­sible to ­cover the low ­part, due to ­rigidity of the ­device ­used, in 1 ­case of ­large ­iliac aneu­rysm ­there was incom­plete imme­diate exclu­sion. No com­pli­ca­tion ­during the pro­ce­dure. ­Four ­patients devel­oped non-infec­tious ­fever/­local ­pain. ­Eight throm­boses ­occurred: 2 at ­iliac, 1 at ­femoral and 5 at the pop­li­teal ­level. All ­other ­stents ­remained ­patent, the aneu­rysms com­pletely ­excluded ­over a ­mean ­follow-up of 20.6±13.2 m, max­imum 61 m. Pri­mary ­patency: all ­lesions 82%, ­iliac 92%, femor­o­pop­li­teal 78%. Sec­on­dary ­patency: all ­lesions 88%, ­iliac 96%, femor­o­pop­li­teal 86%.
Con­clu­sion. Per­cut­aneous endo­lu­minal treat­ment of periph­eral aneu­rysms ­seems ­safe and effec­tive ­with ­high tech­nical suc­cess and ­good ­long-­term ­results, ­except for pop­li­teal local­iza­tion. It ­could be an alter­na­tive to sur­gery.

top of page